| Polycythemia vera | JAK2 | 4 | Link |
| Myelofibrosis | JAK2 | 4 | Link |
n/a | Myeloproliferative disorder | JAK2 | 4 | Link |
| Thrombocythemia | JAK2 | 4 | Link |
| Gastric cancer | MET | 3 | Link |
| Hemangioma | KDR | 5 | Link |
| Leukemia | JAK2 | 4 | Link |
n/a | Budd-Chiari syndrome | JAK2 | 4 | Link |
n/a | Toxoplasmosis | JAK2 | 4 | Link |
n/a | Leishmaniasis | JAK2 | 4 | Link |
n/a | Tuberculosis | JAK2 | 4 | Link |
n/a | Measles | JAK2 | 4 | Link |
n/a | Herpes simplex infection | JAK2 | 4 | Link |
n/a | Influenza A | JAK2 | 4 | Link |
| Renal cell carcinoma | MET | 3 | Link |
n/a | Cholangiocarcinoma | MET | 3 | Link |
| Central hypoventilation syndrome | RET | 2 | Link |
n/a | Congenital central hypoventilation syndrome | RET | 2 | Link |
n/a | Medullary thyroid carcinoma | RET | 2 | Link |
| Multiple endocrine neoplasia | RET | 2 | Link |
| Renal agenesis | RET | 2 | Link |
| Pheochromocytoma | RET | 2 | Link |
| Hirschsprung disease | RET | 2 | Link |
n/a | Renal agenesis and Renal adysplasia | RET | 2 | Link |
n/a | Malaria | MET | 3 | Link |
n/a | Epithelial cell signaling in Helicobacter pylori infection | MET | 3 | Link |
| Melanoma | MET | 3 | Link |
n/a | Autism suseptibility | MET | 3 | Link |
n/a | Thyroid cancer | RET | 2 | Link |
| Hepatocellular carcinoma | MET | 3 | Link |